The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ESPERION THERAPEUTICS INC NE | COMMON | 29664W105 | 15,735 | 340,000 | SH | DFND | 1 | 0 | 0 | 340,000 | |
| MEDICINES CO | COMMON | 584688105 | 102,756 | 2,703,389 | SH | DFND | 1 | 0 | 0 | 2,703,389 | |
| MEDICINES CO | COMMON | 584688105 | 29,580 | 778,210 | SH | DFND | 0 | 0 | 778,210 | ||
| MIRATI THERAPEUTICS INC | COMMON | 60468T105 | 10,515 | 2,880,702 | SH | DFND | 1 | 0 | 0 | 2,880,702 | |